Skip to content

Physiological predictors of response to exposure, relaxation, and rescripting therapy for chronic nightmares in a randomized clinical trial.

Joanne L. Davis, Jamie L Rhudy, Kristi E. Pruiksma, Patricia Byrd, Amy E. Williams, Klanci M McCabe, Emily J Bartley

Journal of Clinical Sleep Medicine December 1, 2011 DOI: 10.5664/jcsm.1466 (opens in new tab)

Study at a glance

AI-extracted from the abstract
Characteristics Randomized controlled trial Peer reviewed
Sample size 47
Population Trauma-exposed individuals with nightmares
Interventions Exposure relaxation
Duration 6-month follow-up
Topics Dreaming
Keywords Humans Chronic disease Electroencephalography Treatment outcome Relaxation Risk assessment Follow-up studies Dreams Stress disorders, post-traumatic Neuropsychological tests Reference values Middle aged Female Young adult Sleep wake disorders Cognitive behavioral therapy Imagery, psychotherapy Nightmares Posttraumatic stress disorder Sleep quality Physiological assessment
Key findings ERRT produced improvements relative to a waitlist control at one week post-treatment, and at six-month follow-up the authors report significant improvements in nightmare frequency and severity, PTSD symptoms, depression, sleep quality and quantity, physical health symptoms, anger, dissociation, tension-reduction behaviors, and quality of life. Treatment-related decreases in heart rate, skin conductance, and corrugator activity during nightmare imagery correlated with improvements in sleep, nightmare and PTSD severity, fear of sleep, and physical health.

Abstract

Study

Objectives: Evidence supports the use of cognitive behavioral therapies for nightmares in trauma-exposed individuals. This randomized clinical trial replicated a study of exposure, relaxation, and rescripting therapy(ERRT) and extended prior research by including broad measures of mental health difficulties, self-reported physical health problems, and quality of life. Additionally, physiological correlates of treatment-related change assessed from a script-driven imagery paradigm were examined.

Methods: Forty-seven individuals were randomized to treatment or waitlist control.

Results: The treatment group demonstrated improvements relative to the control group at the one-week post-treatment assessment. At the 6-month follow-up assessment, significant improvements were found for frequency and severity of nightmares, posttraumatic stress disorder symptoms, depression, sleep quality and quantity, physical health symptoms, anger, dissociation, and tension reduction behaviors. Participants also reported improved quality of life. Treatment-related decreases in heart rate to nightmare imagery were correlated with improvements in sleep quality and quantity; treatment-related decreases in skin conductance to nightmare imagery were correlated with improvements in nightmare severity, posttraumatic stress disorder symptom severity, sleep quality, and fear of sleep; and treatment-related decreases in corrugator activity to nightmare imagery were correlated with improved physical health.

Conclusions: Findings provide additional support for the use of ERRT in treating nightmares and related difficulties and improving sleep.

Comparable studies

Other randomized controlled trials on dreaming, most cited first.

Study Year Design Participants
Efficacy of a Cognitive‐Behavioral Treatment for Insomnia and Nightmares in Afghanistan and Iraq Veterans With PTSD Combat veterans of Operation Enduring Freedom and/or Operation Iraqi Freedom (mean age... 2013 Randomized controlled trial n = 40
Lucid Dreaming Treatment for Nightmares: A Pilot Study Chronic nightmare sufferers 2006 Randomized controlled trial n = 23
Testing the involvement of the prefrontal cortex in lucid dreaming: A tDCS study Participants spending three consecutive nights in a sleep laboratory 2013 Randomized controlled trial n = 19
Pre-sleep treatment with galantamine stimulates lucid dreaming: A double-blind, placebo-controlled, crossover study Adults with high dream recall and an interest in lucid dreaming 2018 Randomized crossover trial n = 121
Studies with lucid dreaming as add-on therapy to Gestalt therapy Adults with nightmares (ICD-10: F51.5) at least twice a week 2015 Randomized controlled trial n = 32

Citations in the library

Explore topics